BioLab Holdings Achieves Great Place to Work Certification in 2026 BioLab Holdings proudly announces its Great Place to Work certification, reflecting its dedication to an inclusive and safe workplace culture.

BioLab Holdings Achieves Great Place to Work Certification in 2026 #United_States #Phoenix #Certification #BioLab_Holdings #work_culture

Imbed Biosciences Receives Major Investment to Enhance Wound Care Technology Imbed Biosciences has secured a strategic investment from BioLab Holdings, aimed at advancing their innovative wound care solutions and expanding market reach.

Imbed Biosciences Receives Major Investment to Enhance Wound Care Technology #USA #Middleton #BioLab_Holdings #Imbed_Biosciences #SAM_Technology

BioLab Holdings Expands Portfolio with Investment in Advanced Antimicrobials BioLab Holdings partners with Imbed Biosciences to enhance wound care through innovative antimicrobial solutions, boosting patient treatment options.

BioLab Holdings Expands Portfolio with Investment in Advanced Antimicrobials #United_States #Phoenix #BioLab_Holdings #Imbed_Biosciences #Microlyte

BioLab Holdings Expands Workforce to Enhance Wound Care Innovations and Community Support BioLab Holdings, Inc. has announced significant team growth, hiring 37 new professionals to enhance its wound care solutions and support local economic growth.

BioLab Holdings Expands Workforce to Enhance Wound Care Innovations and Community Support #USA #Phoenix #Wound_Care #BioLab_Holdings #Jaime_Leija

BioLab Holdings Launches Clinical Trials to Transform Chronic Wound Treatment in Medicine BioLab Holdings, Inc. is initiating several clinical trials aimed at enhancing the treatment of chronic wounds, including diabetic foot ulcers and venous leg ulcers, reinforcing its commitment to innovative wound care solutions.

BioLab Holdings Launches Clinical Trials to Transform Chronic Wound Treatment in Medicine #United_States #Phoenix #Clinical_Trials #BioLab_Holdings #Chronic_Wounds

BioLab Holdings Partners with Terraplasma Medical to Innovate Wound Care BioLab Holdings, Inc. announces a strategic investment and partnership with Terraplasma Medical to bring innovative cold plasma technology to wound care in the U.S.

BioLab Holdings Partners with Terraplasma Medical to Innovate Wound Care #USA #Phoenix #BioLab_Holdings #cold_plasma #terraplasma_medical

BioLab Holdings Invests in Groundbreaking Cold Plasma Technology for Wound Care BioLab Holdings has partnered with terraplasma medical to enhance wound care solutions using innovative cold atmospheric plasma technology. This marks a significant investment aimed at advancing antimicrobial treatments.

BioLab Holdings Invests in Groundbreaking Cold Plasma Technology for Wound Care #USA #Phoenix #Wound_Care #BioLab_Holdings #terraplasma_medical

BioLab Holdings Strengthens AI Diagnostic Technology Partnership for Wound Care Innovation BioLab Holdings' recent strategic investment in AI technology aims to revolutionize wound diagnosis and enhance patient outcomes across the U.S. healthcare system.

BioLab Holdings Strengthens AI Diagnostic Technology Partnership for Wound Care Innovation #USA #AI_Technology #Phoenix #BioLab_Holdings #cureVision

BioLab Holdings Partners with cureVision to Revolutionize Wound Care Through AI Technology BioLab Holdings, Inc. has formed a strategic partnership with cureVision to innovate wound care diagnostics using AI-driven technology, enhancing patient outcomes.

BioLab Holdings Partners with cureVision to Revolutionize Wound Care Through AI Technology #United_States #AI_Technology #Phoenix #BioLab_Holdings #cureVision

FDA Approves Five Innovative Amniotic Membrane Allografts by BioLab Holdings for Advanced Wound Care BioLab Holdings, Inc. has received FDA recognition for five of its amniotic membrane allografts, enhancing wound care solutions through advanced technology and better patient accessibility.

FDA Approves Five Innovative Amniotic Membrane Allografts by BioLab Holdings for Advanced Wound Care #USA #Phoenix #Wound_Care #BioLab_Holdings #Amniotic_Membrane

BioLab Holdings, Inc. Initiates Pioneering Clinical Trial for Wound Care Solutions BioLab Holdings, Inc. has launched its most comprehensive clinical study to test human placental membrane products, aiming to enhance chronic wound care.

BioLab Holdings, Inc. Initiates Pioneering Clinical Trial for Wound Care Solutions #USA #Phoenix #Clinical_Trial #BioLab_Holdings #Human_Placental_Membrane

BioLab Holdings Launches Comprehensive Clinical Trial for Chronic Wound Care with Amnion Grafts BioLab Holdings, Inc. has initiated a multicenter trial to assess the efficacy of amnion grafts for treating chronic wounds, aiming for significant advancements in wound care.

BioLab Holdings Launches Comprehensive Clinical Trial for Chronic Wound Care with Amnion Grafts #United_States #Phoenix #BioLab_Holdings #Wound_Healing #Amnion_Grafts

BioLab Holdings Teams Up with Real Collagen for Innovative Wound Care Solutions BioLab Holdings is collaborating with Real Collagen GmbH to develop groundbreaking wound care products utilizing fish collagen technology to enhance patient care.

BioLab Holdings Teams Up with Real Collagen for Innovative Wound Care Solutions #USA #Phoenix #Wound_Care #BioLab_Holdings #Real_Collagen

BioLab Holdings Partners with Real Collagen to Innovate Wound Care Solutions BioLab Holdings, a Phoenix-based medical manufacturer, has partnered with Real Collagen GmbH to develop innovative wound care products using fish collagen.

BioLab Holdings Partners with Real Collagen to Innovate Wound Care Solutions #USA #Phoenix #Wound_Care #BioLab_Holdings #Real_Collagen_GmbH

BioLab Holdings, Inc. Gains Approval for Membrane Wrap™ Trial Focusing on Wound Healing BioLab Holdings Inc. has received IRB approval for a trial of its innovative Membrane Wrap™ for treating venous leg ulcers, aiming to enhance wound healing in the elderly population.

BioLab Holdings, Inc. Gains Approval for Membrane Wrap™ Trial Focusing on Wound Healing #United_States #Phoenix #BioLab_Holdings #Wound_Healing #Membrane_Wrap

BioLab Holdings Announces Promising Results from Animal Study on Innovative Wound Care Product BioLab Holdings, Inc. revealed encouraging results from a 25-day animal study of its new wound care product, showing faster healing rates than competitors.

BioLab Holdings Announces Promising Results from Animal Study on Innovative Wound Care Product #United_States #Phoenix #Wound_Care #BioLab_Holdings #Animal_Study